Regulation of Insulin-Like Growth Factor Binding Protein-1 during Protracted Critical Illness
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
IGF binding protein-1 (IGFBP-1), an important regulator of IGF bioavailability, has been shown to correlate with mortality in critically ill patients. In the liver, IGFBP-1 is transcriptionally repressed by insulin, and it is therefore a potential marker of hepatic insulin sensitivity. We have recently shown that, compared with conventional treatment, maintenance of normoglycemia with intensive insulin therapy decreased morbidity and mortality of continuously fed critically ill patients. This study compares the effect of conventional and intensive insulin therapy on IGFBP-1 and assesses its predictive value for mortality. In 363 patients who were dependent on intensive care for more than 7 d and were randomly assigned to either conventional or intensive insulin therapy, serum IGFBP-1 levels were measured on admission, on d 1, 8, 15, 22, and 29, and on the day of intensive care unit discharge or death. In addition, IGFBP-1 and phosphoenolpyruvate carboxykinase mRNA levels were measured by real-time RT-PCR in postmortem liver biopsies obtained from 74 patients who died in the intensive care unit. Although intensive insulin treatment lowered glycemia, it had no effect on IGFBP-1 serum levels. Instead, serum IGFBP-1 concentration was significantly higher in patients who ultimately died, and it differentiated nonsurvivors from survivors 3 wk before death. The predictive value of serum IGFBP-1 for mortality was similar to that of the APACHE-II score. Like circulating IGFBP-1, hepatic mRNA levels of IGFBP-1 and the similarly insulin-regulated gene, phosphoenolpyruvate carboxykinase, were not significantly different between conventional and intensive insulin therapy groups. These data suggest that hepatic insulin resistance in prolonged critically ill patients, reflected by high serum IGFBP-1 levels, is not overcome by intensive insulin therapy, and that this may affect patient outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
REGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729
Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions
Lee, P. D. K., Giudice, L. C., Conover, C. A., & Powell, D. R. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44182 · Cited by 523 · cited 1×
“The two dominant metabolic influences on IGFBP-1 gene expression appear to be insulin, which is suppressive, and the availability of hepatic substrate, with IGFBP-1 stimulated by substrate deprivation (7).”
BackgroundCounts, D. R., Gwirtsman, H., Carlsson, L. M., Lesem, M., & Cutler, G. B. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1381372 · Cited by 344
Prediction of outcome in intensive care patients using endocrine parameters
Rothwell, P. M., & Lawler, P. G. (1995) · Critical Care Medicine · doi:10.1097/00003246-199501000-00015 · Cited by 219
Van den Berghe, G., Baxter, R. C., Weekers, F., Wouters, P., Bowers, C. Y., Iranmanesh, A., Veldhuis, J. D., & Bouillon, R. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01255.x · Cited by 134
Self-citationRoss, R. J. M., Miell, J. P., Holly, J. M. P., Maheshwari, H., Norman, M., Abdulla, A. F., & Buchanan, C. R. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03549.x · Cited by 93
Cited by
How does blood glucose control with insulin save lives in intensive care?
Van den Berghe, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423506 · Cited by 550
Self-citationIntensive insulin therapy protects the endothelium of critically ill patients
Langouche, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25385 · Cited by 467
Stress-hyperglycemia, insulin and immunomodulation in sepsis
Marik, P. E., & Raghavan, M. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2167-y · Cited by 419
Toward Understanding Tight Glycemic Control in the ICU
Marik, P. E., & Preiser, J.-C. (2010) · Chest · doi:10.1378/chest.09-1737 · Cited by 365
Mesotten, D., Swinnen, J. V., Vanderhoydonc, F., Wouters, P. J., & Van den Berghe, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030760 · Cited by 288
Self-citationSchefold, J. C., Bierbrauer, J., & Weber-Carstens, S. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0010-6 · Cited by 268
Peeters, R. P., Wouters, P. J., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0535 · Cited by 251
Insufficient Activation of Autophagy Allows Cellular Damage to Accumulate in Critically Ill Patients
Vanhorebeek, I., Gunst, J., Derde, S., Derese, I., Boussemaere, M., Güiza, F., Martinet, W., Timmermans, J.-P., D'Hoore, A., Wouters, P. J., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2563 · Cited by 241
Weber-Carstens, S., Deja, M., Koch, S., Spranger, J., Bubser, F., Wernecke, K. D., Spies, C. D., Spuler, S., & Keh, D. (2010) · Critical Care · doi:10.1186/cc9074 · Cited by 132
Thorell, A., Rooyackers, O., Myrenfors, P., Soop, M., Nygren, J., & Ljungqvist, O. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1118 · Cited by 90
Hormonal and metabolic strategies to attenuate catabolism in critically ill patients
Vanhorebeek, I., & Berghe, G. V. D. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.07.007 · Cited by 52
Self-citationGielen, M., Mesotten, D., Wouters, P. J., Desmet, L., Vlasselaers, D., Vanhorebeek, I., Langouche, L., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2240 · Cited by 22
Self-citation
Metadata
- Authors
- Mesotten, D., Delhanty, P. J. D., Vanderhoydonc, F., Hardman, K. V., Weekers, F., Baxter, R. C., & van den Berghe, G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-12
- Volume
- 87
- Issue
- 12
- Pages
- 5516-5523
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2134644322
- Cited by
- 141
- References
- 7
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.